MENU
FTXH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

FTXH stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq U... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
FTXH
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for FTXH with price predictions
Oct 21, 2026

FTXH in upward trend: 10-day moving average broke above 50-day moving average on October 20, 2026

The 10-day moving average for FTXH crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on FTXH as a result. In 66 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for FTXH just turned positive on October 15, 2026. Looking at past instances where FTXH's MACD turned positive, the stock continued to rise in 37 of 49 cases over the following month. The odds of a continued upward trend are 76%.

FTXH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where FTXH advanced for three days, in 253 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FTXH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

FTXH broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Moderna (NASDAQ:MRNA), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq U.S. Smart Pharmaceuticals TM Index. The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

Market Cap

The average market capitalization across the First Trust Nasdaq Pharmaceuticals ETF (FTXH) ETF is 74.85B. The market cap for tickers in the group ranges from 3.06B to 1.13T. LLY holds the highest valuation in this group at 1.13T. The lowest valued company is ELVN at 3.06B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF (FTXH) ETF was 23%. For the same ETF, the average monthly price growth was 33%, and the average quarterly price growth was 312%. TNGX experienced the highest price growth at 22%, while KRYS experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF (FTXH) ETF was -19%. For the same stocks of the ETF, the average monthly volume growth was 0% and the average quarterly volume growth was -33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 49
Price Growth Rating: 41
SMR Rating: 67
Profit Risk Rating: 58
Seasonality Score: 30 (-100 ... +100)
View a ticker or compare two or three
FTXH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
120 East Liberty Drive, Suite 400Wheaton, Illinois 60187Wheaton
Phone
(800) 621-1675
Web
http://www.ftportfolios.com
FTXH in upward trend: 10-day moving average broke above 50-day moving average on October 20, 2026